(Q79351921)

English

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

scientific article published on 01 January 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Christina Peters

3

object named as

C Peters

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

S Corbacioglu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

J Greil

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

N Wulffraat

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

H J Laws

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

D Dilloo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

B Straham

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

U Gross-Wieltsch

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

K W Sykora

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

A Ridolfi-Lüthy

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

O Basu

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

B Gruhn

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

T Güngör

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

W Mihatsch

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

A S Schulz

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

189-195

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14661036%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver after hemopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation in patients with thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-haploidentical blood progenitor cell transplantation in osteopetrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Venoocclusive disease of the liver following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704329

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79351921&oldid=2220702542"